SG Americas Securities
XFOR icon

SG Americas Securities’s X4 Pharmaceuticals XFOR Stock Holding History

SG Americas Securities’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,050
Closed -$22K – 3675
2025
Q1 		$22K Sell
3,050
-3,055
-50% -$42.1K ﹤0.01% 3374
2024
Q4 		$134K Buy
6,105
+4,272
+233% +$68.1K ﹤0.01% 2508
2024
Q3 		$37K Buy
+1,833
New +$38.3K ﹤0.01% 3298
2024
Q2 		– Sell
-694
Closed -$29K – 3362
2024
Q1 		$29K Sell
694
-895
-56% -$24.9K ﹤0.01% 2839
2023
Q4 		$40K Buy
1,589
+444
+39% +$10.8K ﹤0.01% 2954
2023
Q3 		$37K Buy
+1,145
New +$49.9K ﹤0.01% 2990

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SG Americas Securities's XFOR Position: Q2 2025 in Review

SG Americas Securities sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 3,050 shares — an estimated $22K sold.

SG Americas Securities first reported a position in XFOR in Q3 2023 and held it in 6 quarters. The position peaked at $134K in Q4 2024. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • SG Americas Securities reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 3,050 X4 Pharmaceuticals shares in Q2 2025, an estimated $22K.
  • SG Americas Securities first reported a position in X4 Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • SG Americas Securities's X4 Pharmaceuticals position peaked at $134K in Q4 2024.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.